MODY probability calculator for GCK and HNF1A screening in a multiethnic background population.


Journal

Archives of endocrinology and metabolism
ISSN: 2359-4292
Titre abrégé: Arch Endocrinol Metab
Pays: Brazil
ID NLM: 101652058

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 25 02 2019
accepted: 19 06 2019
pubmed: 3 10 2019
medline: 7 5 2020
entrez: 3 10 2019
Statut: ppublish

Résumé

Objective We aimed to identify the frequency of monogenic diabetes, which is poorly studied in multiethnic populations, due to GCK or HNF1A mutations in patients with suggestive clinical characteristics from the Brazilian population, as well as investigate if the MODY probability calculator (MPC) could help patients with their selection. Subjects and methods Inclusion criteria were patients with DM diagnosed before 35 years; body mass index < 30 kg/m2; negative autoantibodies; and family history of DM in two or more generations. We sequenced HNF1A in 27 patients and GCK in seven subjects with asymptomatic mild fasting hyperglycemia. In addition, we calculated MODY probability with MPC. Results We identified 11 mutations in 34 patients (32.3%). We found three novel mutations. In the GCK group, six cases had mutations (85.7%), and their MODY probability on MPC was higher than 50%. In the HNF1A group, five of 27 individuals had mutations (18.5%). The MPC was higher than 75% in 11 subjects (including all five cases with HNF1A mutations). Conclusion Approximately one third of the studied patients have GCK or HNF1A mutations. Inclusion criteria included efficiency in detecting patients with GCK mutations but not for HNF1A mutations (< 20%). MPC was helpful in narrowing the number of candidates for HNF1A screening.

Identifiants

pubmed: 31576961
pii: S2359-39972019005008101
doi: 10.20945/2359-3997000000173
pmc: PMC10522291
pii:
doi:

Substances chimiques

HNF1A protein, human 0
Hepatocyte Nuclear Factor 1-alpha 0
Glucokinase EC 2.7.1.2

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

17-23

Références

BMJ. 2011 Oct 19;343:d6044
pubmed: 22012810
Diabetes Care. 2001 Apr;24(4):786-8
pubmed: 11315851
Nat Clin Pract Endocrinol Metab. 2008 Apr;4(4):200-13
pubmed: 18301398
Diabetologia. 2012 May;55(5):1265-72
pubmed: 22218698
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Diabetologia. 2010 Dec;53(12):2504-8
pubmed: 20499044
Diabetologia. 2011 May;54(5):1261-3
pubmed: 21350841
Diabetes Res Clin Pract. 2017 Jan;123:134-142
pubmed: 28012402
Ann Clin Biochem. 2013 Sep;50(Pt 5):403-15
pubmed: 23878349
Hum Mol Genet. 2001 Mar 15;10(6):591-7
pubmed: 11230178
Public Health Genomics. 2015;18(1):52-9
pubmed: 25341961
Nucleic Acids Res. 2003 Jul 1;31(13):3812-4
pubmed: 12824425
Diabetes. 1997 Apr;46(4):726-30
pubmed: 9075819
J Clin Endocrinol Metab. 2005 Aug;90(8):4607-14
pubmed: 15928245
Q J Med. 1974 Apr;43(170):339-57
pubmed: 4212169
Clin Endocrinol (Oxf). 2007 Oct;67(4):538-46
pubmed: 17573900
Diabetes Care. 2014;37(1):202-9
pubmed: 24026547
Diabetes Metab. 2011 Dec;37(6):512-9
pubmed: 21683639
Diabetes. 1997 Apr;46(4):720-5
pubmed: 9075818
Clin Genet. 2017 Oct;92(4):388-396
pubmed: 28170077
Diabetes Res Clin Pract. 2016 Sep;119:13-22
pubmed: 27420379
Diabetologia. 2008 Apr;51(4):546-53
pubmed: 18297260
Acta Diabetol. 2016 Oct;53(5):703-8
pubmed: 27106716
Diabetologia. 2007 Nov;50(11):2313-7
pubmed: 17828387
J Clin Endocrinol Metab. 1998 Jun;83(6):2059-65
pubmed: 9626139
PLoS One. 2012;7(6):e38906
pubmed: 22761713

Auteurs

Roberta Magalhães Tarantino (RM)

Departamento de Medicina Interna, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.

Gabriella de Medeiros Abreu (GM)

Laboratório de Genética Humana, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brasil.

Ana Carolina Proença de Fonseca (ACP)

Laboratório de Genética Humana, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brasil.

Rosane Kupfer (R)

Instituto Estadual de Diabetes e Endocrinologia do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.

Maria de Fátima Carvalho Pereira (MFC)

Departamento de Patologia Clínica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.

Mario Campos Júnior (M)

Laboratório de Genética Humana, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brasil.

Lenita Zajdenverg (L)

Departamento de Medicina Interna, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.

Melanie Rodacki (M)

Departamento de Medicina Interna, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH